Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Real-Life Multicenter Experience of the Use of Avatrombopag

Mónica Fernández Pérez, Xabier Gutiérrez López de Ocariz, Carlos Pisón Herrero, Angel Pereda Vicandi, Miren Gabilondo Jalon, Jose María Guinea de Castro, Maria José Ojinaga Begoña, Ana Moreto Quintana, Juan Carlos García-Ruiz, Edwin Uriel Suarez Merchan, Cristina Sierra-Aisa

Blood (2023) 142 (Supplement 1): 5433.

https://doi.org/10.1182/blood-2023-182693

Published: 2023

Journal Articles

A Case Report of a Patient with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan Who Underwent Major Surgery

Míriam Vara, Maite Moreno, Javier Arzuaga, Sara Hormaza, Juan Carlos García-Ruiz

Blood (2023) 142 (Supplement 1): 5656.

https://doi.org/10.1182/blood-2023-182242

Published: 2023

Journal Articles

DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features

Blood (2022) 140 (Supplement 1): 1734–1736.

https://doi.org/10.1182/blood-2022-163728

Published: 2022

Journal Articles

Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and Reverted By IL1β Inhibitors

Blood (2021) 138 (Supplement 1): 3670.

https://doi.org/10.1182/blood-2021-153686

Published: 2021

Journal Articles

Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis

Emanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, Omri Cohen, Juan-Carlos Garcia-Pagan, Marta Magaz, Ettore Porreca, Walter Ageno

Blood (2021) 137 (9): 1233–1240.

https://doi.org/10.1182/blood.2020006827

Published: 2021

Includes: Supplemental data

Journal Articles

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brener Sabando, MD, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Kenny Galvez, MD, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Raimundo Gazitua, MD, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Macarena Roa, MD, Eloisa Riva, MD

Blood (2019) 134 (Supplement_1): 5497.

https://doi.org/10.1182/blood-2019-127555

Published: 2019

Journal Articles

Real World Outcomes with VTD and Cybord Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. Retrospective Cohort Study from Gamm (Grupo Argentino de Mieloma Multiple)

Natalia Paola Schutz, MD MSc, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Dario Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 3301.

https://doi.org/10.1182/blood-2018-99-116243

Published: 2018

Journal Articles

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

Blood (2014) 124 (21): 3980.

https://doi.org/10.1182/blood.V124.21.3980.3980

Published: 2014

Journal Articles

PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene

Blood (2014) 124 (11): 1777–1789.

https://doi.org/10.1182/blood-2014-01-551234

Published: 2014

Includes: Supplemental data

Journal Articles

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis

Jasper H. Smalberg, Edith Koehler, Sarwa Darwish Murad, Aurelie Plessier, Susana Seijo, Jonel Trebicka, Massimo Primignani, Moniek P. M. de Maat, Juan-Carlos Garcia-Pagan, Dominique C. Valla, Harry L. A. Janssen, Frank W. G. Leebeek, for the European Network for Vascular Disorders of the Liver (EN-Vie)

Blood (2011) 117 (15): 3968–3973.

https://doi.org/10.1182/blood-2010-11-319087

Published: 2011

Includes: Supplemental data

Journal Articles

Fibrinogen γ' In the Budd-Chiari Syndrome: Results From a Multicenter Case-Control Study

Jasper Smalberg, PhD, Edith Koehler, PhD, Sarwa Darwish Murad, PhD, Aurelie Plessier, PhD, Juan-Carlos Garcia-Pagan, PhD, Susana Seijó, PhD, Philippe Langlet, PhD, Jonel Trebicka, PhD, Massimo Primignani, PhD, Moniek De Maat, PhD, Dick Rijken, PhD, Dominique Valla, PhD, Harry Janssen, PhD, Frank Leebeek

Blood (2010) 116 (21): 4213.

https://doi.org/10.1182/blood.V116.21.4213.4213

Published: 2010

Journal Articles

JAK2 Germline Genetic Variation In Budd-Chiari Syndrome and Portal Vein Thrombosis

Jasper Smalberg, PhD, Edith Koehler, PhD, Sarwa Darwish Murad, PhD, Aurelie Plessier, PhD, Juan-Carlos Garcia-Pagan, PhD, Susana Seijó, PhD, Philippe Langlet, PhD, Jonel Trebicka, PhD, Massimo Primignani, PhD, Moniek De Maat, PhD, Dominique Valla, PhD, Harry Janssen, PhD, Frank Leebeek

Blood (2010) 116 (21): 4212.

https://doi.org/10.1182/blood.V116.21.4212.4212

Published: 2010

Journal Articles

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome

Jildou Hoekstra, Ana H. C. Guimarães, Frank W. G. Leebeek, Sarwa Darwish Murad, Joyce J. M. C. Malfliet, Aurelie Plessier, Manuel Hernandez-Guerra, Philippe Langlet, Elwyn Elias, Jonel Trebicka, Massimo Primignani, Juan-Carlos Garcia-Pagan, Dominique C. Valla, Dingeman C. Rijken, Harry L. A. Janssen, for the European Network for Vascular Disorders of the Liver (EN-Vie)

Blood (2010) 115 (2): 388–395.

https://doi.org/10.1182/blood-2009-03-211557

Published: 2010

Includes: Supplemental data

Journal Articles

A novel G6PC3 homozygous 1-bp deletion as a cause of severe congenital neutropenia

Juan I. Aróstegui, José Sánchez de Toledo, Mariona Pascal, Carlos García, Jordi Yagüe, Cristina Díaz de Heredia

Blood (2009) 114 (8): 1718–1719.

https://doi.org/10.1182/blood-2009-04-219451

Published: 2009

Journal Articles

Effective Targeting of the PI3-K Pathway in CLL with NVP-BEZ235, a Novel Orally Available Dual PI3K/mTOR Inhibitor

Medhat Shehata, Susanne Schnabl, Dita Demirtas, Stefanie Tauber, Martin Hilgarth, Martin Bilban, Katrina Vanura, Edit Porpaczy, Christa Fonatsch, Stephan Stilgenbauer, MD, PhD, Josef D. Schwarzmeier, Rainer Hubmann, Alexander Gaiger, Christoph Zielinski, MD, Sauveur-Michel Maira, Carlos Garcia-Echeverria, Wolfgang Hackl, Ulrich Jaeger

Blood (2008) 112 (11): 3166.

https://doi.org/10.1182/blood.V112.11.3166.3166

Published: 2008

Journal Articles

Synergistic Interaction of the Heat Shock Protein 90 Inhibitor NVP-AUY922 and the Histone Deacetylase Inhibitor NVP-LBH589 in Multiple Myeloma

Martin Kaiser, Britta Lamottke, Michael R. Jensen, Cornelia Quadt, Carlos Garcia-Echeverria, Maren Mieth, Ulrike Heider, Orhan Sezer

Blood (2008) 112 (11): 5164.

https://doi.org/10.1182/blood.V112.11.5164.5164

Published: 2008

Journal Articles

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

Blood (2008) 111 (10): 4922–4929.

https://doi.org/10.1182/blood-2007-11-125328

Published: 2008

Journal Articles

Tandem Autologous Transplant Versus Reduced Intensity Conditioned Allogeneic Transplant (Allo-RIC) as Second Intensification in Chemosensitive Patients with Multiple Myeloma (MM) Not Achieving Complete Remission (CR) or Near-CR with a First Autologous Transplant. Results from a Spanish PETHEMA/GEM Study.

Blood (2007) 110 (11): 729.

https://doi.org/10.1182/blood.V110.11.729.729

Published: 2007

Journal Articles

Signaling Profile and Anti-Tumor Activity of the Novel HSP90 Inhibitor NVP-AUY922 in Multiple Myeloma.

Thorsten Stühmer, Angela Zöllinger, Daniela Siegmund, Manik Chatterjee, Evelyn Grella, Stefan Knop, Martin Kortüm, Christian Unzicker, Michael R. Jensen, Cornelia Quadt, Patrick Chène, Joseph Schoepfer, Carlos Garcia-Echeverria, Herrmann Einsele, Harald Wajant, Ralf C. Bargou

Blood (2007) 110 (11): 4788.

https://doi.org/10.1182/blood.V110.11.4788.4788

Published: 2007

Journal Articles

Role of JAK 2 Mutation Detection in Budd-Chiari Syndrome (BCS) and Portal Vein Thrombosis (PVT) Associated to MPD.

Jean-Jacques Kiladjian, MD, Francisco Cervantes, MD,PhD, Frank W.G. Leebeek, MD,PhD, Sylvie Chevret, MD,PhD, Dominique Cazals-Hatem, MD, Aurélie Plessier, MD, Christophe Marzac, MD, Bruno Cassinat, MD, Sebastian Raffa, MD, Juan Carlos Garcia-Pagan, MD,PhD, Sarwa Darwish Murad, MD,MSc, Harry L.A. Janssen, MD,PhD, Dominique Valla, MD,PhD, Nicole Casadevall, MD,PhD, Pierre Fenaux, MD,PhD

Blood (2006) 108 (11): 377.

https://doi.org/10.1182/blood.V108.11.377.377

Published: 2006

NARROW

Real-Life Multicenter Experience of the Use of Avatrombopag

A Case Report of a Patient with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan Who Underwent Major Surgery

DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features

Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and Reverted By IL1β Inhibitors

Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Real World Outcomes with VTD and Cybord Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. Retrospective Cohort Study from Gamm (Grupo Argentino de Mieloma Multiple)

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis

Fibrinogen γ' In the Budd-Chiari Syndrome: Results From a Multicenter Case-Control Study

JAK2 Germline Genetic Variation In Budd-Chiari Syndrome and Portal Vein Thrombosis

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome

A novel G6PC3 homozygous 1-bp deletion as a cause of severe congenital neutropenia

Effective Targeting of the PI3-K Pathway in CLL with NVP-BEZ235, a Novel Orally Available Dual PI3K/mTOR Inhibitor

Synergistic Interaction of the Heat Shock Protein 90 Inhibitor NVP-AUY922 and the Histone Deacetylase Inhibitor NVP-LBH589 in Multiple Myeloma

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

Signaling Profile and Anti-Tumor Activity of the Novel HSP90 Inhibitor NVP-AUY922 in Multiple Myeloma.

Role of JAK 2 Mutation Detection in Budd-Chiari Syndrome (BCS) and Portal Vein Thrombosis (PVT) Associated to MPD.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only